14 October 2025
: Case report 
Klebsiella pneumoniae Invasive Syndrome without Liver Abscess: A Case Report
Challenging differential diagnosis, Management of emergency care, Clinical situation which can not be reproduced for ethical reasons, Rare coexistence of disease or pathology
Parth M. Dhamelia
ABCDEF 1*, Dipak R. Mokariya ABCDEF 1, Jaspreet Singh Anand EF 1, Rohit A. Chitale EF 2, Justin Oring ABCDEF 3
DOI: 10.12659/AJCR.949163
Am J Case Rep 2025; 26:e949163
Table 1 Sensitivity reports for Klebsiella pneumoniae.
| Antimicrobial agent (antibiotic) | Tier | MIC (μg/mL) | AST interpretation | BMQ |
|---|---|---|---|---|
| Amoxicillin clavulanate | First | 2.0 | S | 4 |
| Cefuroxime | First | 2.0 | S | 4 |
| Ceftriaxone | First | 0.25 | S | 4 |
| Ciprofloxacin | First | 0.5 | I | NA |
| Gentamicin | First | 1.0 | S | 4 |
| Trimethoprim/sulfamethoxazole | First | 20.0 | S | 2 |
| Cefepime | Second | 0.12 | S | 16 |
| Piperacillin tazobactam | Second | 4.0 | S | 2 |
| Cefoperazone sulbactam | Second | 8.0 | S | 2 |
| Amikacin | Second | 1.0 | S | 16 |
| Imipenem | Third | 0.25 | S | 4 |
| Meropenem | Third | 0.25 | S | 4 |
| Ertapenem | Third | 0.12 | S | 4 |
| Tigecycline | Third | 0.5 | S | 4 |
| Colistin | Third | 0.5 | I | 4 |
| S – susceptible; I – indeterminate; BMQ – breakpoint to minimum inhibitory concentration quotient. | ||||